Anzeige
Mehr »
Donnerstag, 17.07.2025 - Börsentäglich über 12.000 News
Klinisch validiert. Vertriebsbereit. Und kurz vor der FDA-Zulassung.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
182 Leser
Artikel bewerten:
(1)

Pharmaceutical Packaging Equipment Market worth $14.3 billion by 2030 with 6.3% CAGR | MarketsandMarkets

DELRAY BEACH, Fla., July 17, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Equipment Market, valued at US$ 9.75 billion in 2024 stood at US$10.5 billion in 2025 and is projected to advance at a resilient CAGR of 6.3% from 2025 to 2030, culminating in a forecasted valuation of US$14.3 billion by the end of the period. The pharmaceutical packaging equipment market is rapidly growing due to the increasing demand for accurate and high-quality diagnostic imaging, fueled by a rise in chronic diseases and an aging population. Advances in display technology, such as higher resolutions and improved color accuracy, enhance diagnostic precision. Furthermore, the growing adoption of digital healthcare systems, telemedicine, and minimally invasive surgeries is also boosting demand. Increased healthcare spending and investments in medical infrastructure worldwide contribute significantly to the market's sustained growth. In this report, the market is divided into product, formulation, automation, end user, and region.

MarketsandMarkets_Logo

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828

Browse in-depth TOC on "Pharmaceutical Packaging Equipment Market"

361 - Tables
57 - Figures
404 - Pages

By product, Primary packaging equipment plays a crucial role in the pharmaceutical industry, holding the largest market share due to its direct impact on safeguarding the integrity, sterility, and efficacy of various drug formulations. This equipment is essential for an array of dosage forms, including tablets, liquids, and injectables, where maintaining the quality and safety of the product is paramount. One of the key functions of primary packaging is to ensure that pharmaceuticals comply with stringent regulatory standards set by health authorities. This compliance is vital not only for consumer safety but also for the approval processes that allow drugs to enter the market. As the demand for unit-dose formats continues to rise, driven by both patient convenience and the need for accurate dosing, the adoption of advanced primary packaging solutions has surged. Moreover, these advancements are becoming increasingly important in high-throughput packaging environments, where efficiency and speed are critical to meet the growing demands of both generic and branded pharmaceutical production lines. This evolution in packaging technology is helping manufacturers optimize their operations while ensuring that the products maintained within these packages meet the highest standards of quality and effectiveness. Overall, the landscape of primary packaging equipment is shaped by the dual pressures of regulatory compliance and market demand, leading to widespread innovation and adoption across the pharmaceutical sector.

By formulation, Liquid packaging equipment dominates the market, primarily because of the increasing demand for various liquid pharmaceuticals, including syrups, injectables, eye drops, and vaccines. These products necessitate sophisticated packaging solutions that ensure precise, sterile filling and airtight sealing, which is crucial for maintaining product integrity and safety. The precision required in the packaging process is driving many companies to adopt advanced automated systems that enhance efficiency and accuracy. Additionally, there is a growing regulatory focus on contamination-free packaging within the pharmaceutical sector. Regulatory bodies are emphasizing the importance of non-contaminated packaging processes to safeguard public health, which in turn accelerates the demand for high-speed liquid packaging lines that integrate automation and cutting-edge technology. As a result, pharmaceutical manufacturing facilities are increasingly investing in these automated solutions to comply with strict regulations while ensuring production efficiency and reliability. This trend underscores the vital role that liquid packaging equipment plays in meeting the needs of a rapidly evolving pharmaceutical landscape.

By geography, Europe dominates the pharmaceutical packaging equipment market, primarily due to its robust pharmaceutical manufacturing infrastructure, stringent regulatory landscape, and proactive integration of advanced automation technologies. Key players are concentrated in countries like Germany, Switzerland, and Italy, which host major pharma equipment manufacturers and significant global drug producers, resulting in a highly efficient supply chain. The stringent compliance requirements set forth by the EU Good Manufacturing Practices (EU-GMP), the Falsified Medicines Directive (FMD), and serialization mandates have driven the need for high-precision packaging systems that meet regulatory standards. Furthermore, the region's increasing investment in research and development, particularly in biologics and contract manufacturing, along with a strong focus on quality assurance and traceability, solidifies Europe's preeminence in the pharmaceutical packaging equipment sector.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=19845828

The prominent players in the global pharmaceutical packaging equipment market are Syntegon Technology GmbH (Germany), Industria Macchine Automatiche (IMA) S.p.A (Italy), Körber AG (Germany), Coesia S.p. A. (Italy), Marchesini Group S.p.A (Italy), Bausch+Ströbel (Germany), Maschinefabrik Ilshofen GmbH+Co. KG (Germany), Romaco Group (Germany), Uhlmann (Germany), Maquinaria Industries Dara, SL (US).

Syntegon Technology GmbH (Germany):

Syntegon Technology GmbH has established itself as a leading provider in the pharmaceutical packaging industry, offering a wide array of robust solutions tailored to meet the diverse needs of the sector. The company excels in the design, manufacturing, marketing, and distribution of cutting-edge technologies that significantly improve mobility and efficiency in industrial applications. One of the core areas of Syntegon's expertise lies in sophisticated drive and control systems, which empower machinery to operate with precision and reliability. Their advanced packaging technologies are specifically engineered for the pharmaceutical sector, ensuring that products are securely packaged while maintaining compliance with stringent regulations. In addition to pharmaceutical solutions, Syntegon has expanded its offerings to include innovative packaging solutions for consumer goods, catering to a broader market with a focus on sustainability and user experience. The company also emphasizes energy management systems that optimize energy use and reduce waste, contributing to environmentally friendly manufacturing processes. Furthermore, Syntegon integrates building technology solutions that enhance operational efficiency within production facilities, seamlessly combining each element to create a holistic approach to industrial packaging. This comprehensive portfolio positions Syntegon Technology GmbH as a key partner for businesses looking to leverage technological advancements in packaging and production.

Industria Macchine Automatiche (IMA) S.p.A (Italy)

Industria Macchine Automatiche (IMA) S.p.A specializes in a diverse array of primary and secondary packaging equipment, designed to meet the varied needs of different industries, particularly pharmaceuticals. Over the past several years, the company has experienced a consistent upward trend in total revenue, largely driven by a substantial increase in the demand for its packaging solutions tailored for pharmaceutical products. This growth is attributed to the rising global emphasis on healthcare and the need for reliable packaging solutions that ensure product safety and integrity. The company has established extensive sales and distribution networks that reach more than 80 countries worldwide, enabling it to effectively cater to a broad customer base. To support its global operations, IMA operates several state-of-the-art manufacturing facilities located in key regions, including Italy, Germany, France, Switzerland, Spain, the United Kingdom, the United States, India, Malaysia, China, and Argentina. This strategic geographical distribution of production sites not only enhances the company's ability to meet local demand but also optimizes operational efficiencies. To maintain its competitive edge in the rapidly evolving packaging market and strategically increase its market share, the company is actively pursuing acquisitions. By broadening its product portfolio through these acquisitions, the company aims to diversify its offerings and enhance its technological capabilities, while also expanding its presence in emerging markets and established regions alike. This proactive approach positions the company to better respond to changing customer needs and industry trends.

Korber AG (Germany)

Körber AG - is a prominent player in the pharmaceutical packaging industry, renowned for its development and provision of cutting-edge technologies. The company specializes in a range of offerings, including advanced standard packaging systems and inspection machines that ensure the quality and safety of pharmaceutical products. In addition, Körber AG provides comprehensive track and trace solutions that enhance supply chain transparency and regulatory compliance, as well as tailored systems designed for patient-specific pharmaceutical solutions, catering to the growing demand for personalized medication. With a robust distribution network spanning the Americas, Europe, and Asia, Körber AG has successfully established itself in multiple markets. However, its presence in Latin America, a region identified as a high-growth market for pharmaceutical packaging equipment, remains relatively limited. This geographic gap presents both challenges and opportunities for the company as it seeks to expand its footprint in this promising area. Furthermore, Körber AG's approach to innovation has room for enhancement, as the company exhibits a constrained focus on new product developments. This limitation could potentially hinder its competitiveness in an industry that thrives on technological advancements and evolving customer needs. Nevertheless, the company has strategically pursued inorganic growth through acquisitions, which has significantly bolstered its market position. This strategy has enabled Körber AG to establish a stronghold in various segments of the industry, providing long-term benefits and ensuring adaptability in a rapidly changing marketplace. By continuing to leverage acquisitions while enhancing its focus on innovation, Körber AG can position itself more favorably in the competitive landscape of pharmaceutical packaging.

For more information, Inquire Now!

Related Reports:

Active Pharmaceutical Ingredient Market

Pharmaceutical Drying Equipment Market

Empty Capsules Market

Pharmaceutical Metal Detector Market

Pharmaceutical Contract Manufacturing Market

Get access to the latest updates on Pharmaceutical Packaging Equipment Companies and Pharmaceutical Packaging Equipment Market Size

About MarketsandMarkets:

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo:https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/pharmaceutical-packaging-equipment-market-worth-14-3-billion-by-2030-with-6-3-cagr--marketsandmarkets-302507713.html

© 2025 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.